[HTML][HTML] A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.

J Hockenhull, M Elremeli, MG Cherry… - Health Technology …, 2012 - ncbi.nlm.nih.gov
BACKGROUND Each year in the UK, there are between two and nine deaths from
anaphylaxis caused by bee and wasp venom. Anaphylactic reactions can occur rapidly …

[引用][C] A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen (R) for the treatment of bee and wasp venom allergy

J Hockenhull, M Elremeli, MG Cherry… - Health Technology …, 2012 - hero.epa.gov
A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen (R) for the
treatment of bee and wasp venom allergy | Health & Environmental Research Online (HERO) …

[HTML][HTML] A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.

J Hockenhull, M Elremeli, MG Cherry… - Health Technology …, 2012 - europepmc.org
Background Each year in the UK, there are between two and nine deaths from anaphylaxis
caused by bee and wasp venom. Anaphylactic reactions can occur rapidly following a sting …

[HTML][HTML] A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.

J Hockenhull, M Elremeli, MG Cherry… - NIHR Health …, 2012 - ncbi.nlm.nih.gov
Background Each year in the UK there are between two and nine deaths from anaphylaxis
caused by bee and wasp venom. Anaphylactic reactions to bee and wasp venom are a …

[PDF][PDF] A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy

J Hockenhull, M Elremeli, MG Cherry… - Health Technology …, 2012 - scholar.archive.org
A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for
the treatment of bee and wasp venom Page 1 Health Technology Assessment 2012; Vol. 16 …

A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy

J Hockenhull, M Elremeli, MG Cherry… - Health technology …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Each year in the UK, there are between two and nine deaths from anaphylaxis
caused by bee and wasp venom. Anaphylactic reactions can occur rapidly following a sting …

[PDF][PDF] A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy

J Hockenhull, M Elremeli, MG Cherry… - Health Technology …, 2012 - academia.edu
Background Each year in the UK there are between two and nine deaths from anaphylaxis
caused by bee and wasp venom. Anaphylactic reactions to bee and wasp venom are a …

[引用][C] A systematic review of the clinical effectiveness and cost effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy

J Hockenhull, M Elremeli, MG Cherry… - Health Technology …, 2012 - journalslibrary.nihr.ac.uk
Background Each year in the UK, there are between two and nine deaths from anaphylaxis
caused by bee and wasp venom. Anaphylactic reactions can occur rapidly following a sting …

A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy

J Hockenhull, M Elremeli, MG Cherry… - Health Technology …, 2012 - orca.cardiff.ac.uk
Background Each year in the UK, there are between two and nine deaths from anaphylaxis
caused by bee and wasp venom. Anaphylactic reactions can occur rapidly following a sting …

[PDF][PDF] A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy

J Hockenhull, M Elremeli, MG Cherry… - Health Technology …, 2012 - academia.edu
Background Each year in the UK there are between two and nine deaths from anaphylaxis
caused by bee and wasp venom. Anaphylactic reactions to bee and wasp venom are a …